David S. McClintock

David S. McClintock

Auto-generated profile, based on publicly available information

David S. McClintock

Department of Laboratory Medicine and Pathology, Division of Computational Pathology and Informatics, Mayo Clinic , Rochester, MN

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in EBioMedicine
Verified
Journal Article
Open access
MBM. Alvaro Berbís
M. Alvaro Berbís
DMDavid S. McClintock
David S. McClintock
ABAndrey Bychkov
Andrey Bychkov
JLJeroen Van der Laak
Jeroen Van der Laak
LPLiron Pantanowitz
Liron Pantanowitz
JSJeanne Shen
Jeanne Shen
Artificial intelligence (AI) is rapidly fuelling a fundamental transformation in the practice of pathology. However, clinical integration remains challenging, with no AI algorithms to date in routine adoption within typical anatomic pathology (AP) laboratories. This survey gathered current expert perspectives and expectations regarding the role of AI in AP from those with first-hand computational pathology and AI experience. Perspectives were solicited using the Delphi method from 24 subject matter experts between December 2020 and February 2021 regarding the anticipated role of AI in pathology by the year 2030. The study consisted of three consecutive rounds: 1) an open-ended, free response questionnaire generating a list of survey items; 2) a Likert-scale survey scored by experts and analysed for consensus; and 3) a repeat survey of items not reaching consensus to obtain further expert consensus. Consensus opinions were reached on 141 of 180 survey items (78.3%). Experts agreed that AI would be routinely and impactfully used within AP laboratory and pathologist clinical workflows by 2030. High consensus was reached on 100 items across nine categories encompassing the impact of AI on (1) pathology key performance indicators (KPIs) and (2) the pathology workforce and specific tasks performed by (3) pathologists and (4) AP lab technicians, as well as (5) specific AI applications and their likelihood of routine use by 2030, (6) AI's role in integrated diagnostics, (7) pathology tasks likely to be fully automated using AI, and (8) regulatory/legal and (9) ethical aspects of AI integration in pathology. This systematic consensus study details the expected short-to-mid-term impact of AI on pathology practice. These findings provide timely and relevant information regarding future care delivery in pathology and raise key practical, ethical, and legal challenges that must be addressed prior to AI's successful clinical implementation. No specific funding was provided for this study.

31 July 2023 in Journal of Medical Imaging
Verified
Journal Article
Open access
PDF file
MZMark D. Zarella
Mark D. Zarella
DMDavid S. McClintock
David S. McClintock
HBHarsh Batra
Harsh Batra
RGRama R. Gullapalli
Rama R. Gullapalli
MVMichael Valante
Michael Valante
EAEsther Abels
Esther Abels
Digital pathology (DP) is a blanket term encompassing the tools, systems, enabling infrastructure, and associated metadata used when digitizing pathology slides into whole-slide images (WSIs).1,2 Over the last 20 years, technology has advanced to the point at which WSIs (often gigabytes in size) can be captured in minutes and presented to a pathologist for multiple purposes, such as telepathology, research, education, and primary diagnosis (i.e., digital signout). Digitization has many potential benefits, both for pathology laboratories and patients, by introducing efficiencies in distribution/sharing, recall, and reuse of pathology assets. It also provides the required substrate for digital image analysis of histopathology. Although image analysis of WSIs is not new and has been in use for well over ten years,3 recent advances in machine learning and computing have greatly expanded image analysis performance and capabilities. Linking image analysis with other clinical data and concepts is termed “computational pathology” and has become heavily dependent on the use of artificial intelligence (AI), expanding the potential for dramatic improvements in pathology automation, diagnostic accuracy, and treatment guidance.1,4,5

1 October 2023 in Journal of Pathology Informatics
Verified
Journal Article
Open access
SHSteven Hart
Steven Hart
NHNoah G. Hoffman
Noah G. Hoffman
PGPeter Gershkovich
Peter Gershkovich
CCChancey Christenson
Chancey Christenson
DMDavid S. McClintock
David S. McClintock
VBVictor Brodsky
Victor Brodsky
In this paper, we consider the current and potential role of the latest generation of Large Language Models (LLMs) in medical informatics, particularly within the realms of clinical and anatomic pathology. We aim to provide a thorough understanding of the considerations that arise when employing LLMs in healthcare settings, such as determining appropriate use cases and evaluating the advantages and limitations of these models.

4 January 2023 in The Journal of Applied Laboratory Medicine
Verified
Journal Article
Open access
PDF file
Ankush U. PatelAnkush U. Patel
Ankush U. Patel
CWChristopher L Williams
Christopher L Williams
SHSteven Hart
Steven Hart
CGChristopher A Garcia
Christopher A Garcia
TDThomas J S Durant
Thomas J S Durant
DMDavid S McClintock
David S McClintock
Background: Network-connected medical devices have rapidly proliferated in the wake of recent global catalysts, leaving clinical laboratories and healthcare organizations vulnerable to malicious actors seeking to ransom sensitive healthcare information. As organizations become increasingly dependent on integrated systems and data-driven patient care operations, a sudden cyberattack and the associated downtime can have a devastating impact on patient care and the institution as a whole. Cybersecurity, information security, and information assurance principles are, therefore, vital for clinical laboratories to fully prepare for what has now become inevitable, future cyberattacks. Content: This review aims to provide a basic understanding of cybersecurity, information security, and information assurance principles as they relate to healthcare and the clinical laboratories. Common cybersecurity risks and threats are defined in addition to current proactive and reactive cybersecurity controls. Information assurance strategies are reviewed, including traditional castle-and-moat and zero-trust security models. Finally, ways in which clinical laboratories can prepare for an eventual cyberattack with extended downtime are discussed. Summary: The future of healthcare is intimately tied to technology, interoperability, and data to deliver the highest quality of patient care. Understanding cybersecurity and information assurance is just the first preparative step for clinical laboratories as they ensure the protection of patient data and the continuity of their operations.

12 July 2025 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
CGChristopher A Garcia
Christopher A Garcia
KRKatelyn A Reed
Katelyn A Reed
ELEric Lantz
Eric Lantz
PDPatrick Day
Patrick Day
MZMark D Zarella
Mark D Zarella
DMDavid S McClintock
David S McClintock
Objective: Despite exponential growth in artificial intelligence (AI) research for laboratory medicine and pathology, a significant gap exists between model development and clinical AI implementation. This article introduces a structured framework, the Clinical AI Readiness Evaluator (CARE), to bridge this gap and support the responsible adoption of AI in clinical laboratory settings. Methods: Building upon the Machine Learning Technology Readiness Levels framework, we developed CARE specifically for the clinical laboratory environment by incorporating health care–specific requirements, regulatory considerations, and workflow integration needs. This framework was iteratively refined through practical application across diverse AI use cases within laboratory medicine and pathology. Results: The CARE framework provides a systematic approach to AI development and implementation through 8 component workstreams: clinical use case, data, data pipeline, code, clinical user experience, clinical technology infrastructure, clinical orchestration, and regulatory compliance. Unlike generic AI frameworks, CARE distinguishes itself by emphasizing both health care and laboratory workflow integration, regulatory requirements, ethical considerations, and comprehensive validation for clinical contexts. The framework accommodates both internally developed models and commercial AI solutions, providing clear guidance through technology readiness levels and structured review processes. Conclusions: The CARE framework addresses the unique challenges of implementing AI in laboratory medicine and pathology by providing a comprehensive roadmap from initial concepts through clinical deployment and maintenance. This article, the first in a series of 4, establishes the foundational AI lifecycle framework, while subsequent articles will explore data documentation, ethical AI considerations, and governance structures. By adopting this structured approach, laboratories can responsibly harness AI’s potential to enhance diagnostic accuracy and operational efficiencies and, ultimately, improve patient care.

6 September 2024 in Mayo Clinic Proceedings: Digital Health
Verified
Journal Article
Open access
BLBrenna Loufek
Brenna Loufek
DVDavid Vidal
David Vidal
DMDavid S. McClintock
David S. McClintock
MLMark Lifson
Mark Lifson
EWEric Williamson
Eric Williamson
DPDarrell S. Pardi
Darrell S. Pardi
Health care organizations are building, deploying, and self-governing digital health technologies (DHTs), including artificial intelligence, at an increasing rate. This scope necessitates expertise and quality infrastructure to ensure that the technology impacting patient care is safe, effective, and ethical throughout its lifecycle. The objective of this article is to describe Mayo Clinic’s approach for embedding internal accountability as a case study for other health care institutions seeking modalities for responsible implementation of artificial intelligence–enabled DHTs. Mayo Clinic aims to enable and empower innovators by (1) building internal skills and expertise, (2) establishing a centralized review board, and (3) aligning development and deployment processes with regulations, standards, and best practices. In 2022, Mayo Clinic established the Software as a Medical Device Review Board (The Board), an independent body of physicians and domain experts to represent the organization in providing innovators regulatory and risk mitigation recommendations for DHTs. Hundreds of digital health product teams have since benefited from this function, intended to enable responsible innovation in alignment with regulation and state-of-the-art quality management practices. Other health care institutions can adopt similar internal accountability bodies using this framework. Opportunity remains to iterate on Mayo Clinic’s approach in alignment with advancing best practices and enhance representation on The Board as part of standard continuous improvement practices.